[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_610 

# __Rapid diagnostic tests__

## Category to which it belongs

* [Enhanced and expanded array of diagnostic testing tools, technologies, and methods for widespread and reliable screening.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_183.md)

## Closest similar item

* [Diagnostic testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3126.md)
* [Diagnostic testing systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1000.md)
* [Diagnostic testing technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_343.md)
* [Diagnostic tests](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2315.md)
* [Enhanced diagnostic techniques](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2027.md)
* [Rapid antigen tests](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_780.md)
* [Rapid diagnosis](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1.md)
* [Rapid testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1307.md)
* [Rapid testing technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3884.md)
* [Testing and diagnostic technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1556.md)

## Risks linked to this technology

* [Asymptomatic and flu-like symptoms of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1384.md)
* [Asymptomatic transmission of covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6473.md)
* [Continued importation of malaria cases](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6539.md)
* [Difficulty in confirming the actual number of infected people who had already exited but had not been tested or had no symptoms](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7114.md)
* [Hidden transmission of the virus by carriers who are unaware of their infection status.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13514.md)
* [Importation of vector-borne diseases](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13516.md)
* [Insufficient targeted operations for identifying and managing asymptomatic and symptomatic infections](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13760.md)
* [International travel and transmission of denv](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14289.md)
* [Laboratory facilities becoming overwhelmed during epidemics](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14793.md)
* [Lack of capacity to rapidly provide diagnostically confirmed malaria incidence in very low transmission environments](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14809.md)
* [Lag between infection and death](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14811.md)

## This Technology belongs to this TechGroup

* [Biology techs](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)
* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2274.md)

## This Technology belongs to this TechSubgroup

* [Diagnostic and testing tools](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_7.md)
* [Diagnostic testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2052.md)

## This Technology enables the following mitigations

* [Rapid isolation](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_3992.md)

## This technology is mentioned by

* [Cao_analysis_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)
* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_476.md)
* [Ghosh_study_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_555.md)
* [Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_429.md)
* [Semenza_prototype_2015](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_566.md)
* [Sims_future_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_548.md)
* [Suman_sustainability_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_575.md)
* [Tatem_integrating_2014](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_166.md)

